
Naturalne rozwiązania bakteriofagowe dla wyzwań akwakultury
A 2020 study published in Viruses (MDPI), titled “Growing Trend of Fighting Infections in Aquaculture Environment – Opportunities and Challenges of Phage Therapy”, provides a
A 2020 study published in Viruses (MDPI), titled “Growing Trend of Fighting Infections in Aquaculture Environment – Opportunities and Challenges of Phage Therapy”, provides a
A team of scientists from Proteon Pharmaceuticals, the Biobank Lodz, and the University of Agriculture in Cracow has developed an innovative method for identifying strains
We are excited to announce that our bacteriophage-based technology has been granted patent protection by the Polish Patent Office. The invention, “Bacteriophage strains and their
Our research, published in 2020 in Viruses (MDPI), titled ‘Comprehensive Evaluation of the Safety and Efficacy of BAFASAL® Bacteriophage Preparation for the Reduction of Salmonella
We are pleased to share the significant progress Proteon Pharmaceuticals made in 2024. Our company strengthened its market position, advanced its research initiatives, and expanded
Proteon Pharmaceuticals is delighted to announce that the Ministry of Agriculture, Livestock Farming and Supplies (MAPA) in Brazil has registered BAFASAL PRO, our latest bacteriophage-based
Proteon Pharmaceuticals is excited to announce that the European Food Safety Authority (EFSA) has published a positive scientific opinion on our innovative product BAFASAL®. The
At Proteon Pharmaceuticals S.A., we’re dedicated to supporting the growth of future scientists and professionals. This summer, we offered the internships to six students, eager
Proteon Pharmaceuticals is thrilled to announce the obtaining of a new European patent for our pioneering technology: “Method and Kit for Detection of Extraintestinal E.
We are excited to introduce our new video series “Inside Innovation: Micro Talks with the CEO”, launching today on our social media channels. In this